Comparison of four different peptides to enhance accumulation of liposomes into the brain

Journal of Drug Targeting

Volumn 20, Issue 3, 2012, Pages 235-245

  Qin, Yao ^a,b   Zhang, Qianyu ^a   Chen, Huali ^a   Yuan, Wenmin ^a   Kuai, Rui ^a   Xie, Fulan ^a   Zhang, Li ^a   Wang, Xiaoxiao ^a   Zhang, Zhirong ^a   Liu, Ji ^a   He, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

^b Taiji Group   (China)

Author keywords

Brain delivery; Liposome; TAT

Indexed keywords

CELL PENETRATING PEPTIDE; LIPOSOME; TAT PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; ENDOCYTOSIS; ENDOTHELIUM CELL; IN VIVO STUDY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CELL LINE; CELL SURVIVAL; CELL-PENETRATING PEPTIDES; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; ENDOTHELIUM, VASCULAR; INDICATORS AND REAGENTS; LIPOSOMES; MICE; MICE, INBRED STRAINS; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RATS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TISSUE DISTRIBUTION;

EID: 84863233161     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2011.639022     Document Type: Article

References (40)

1. Azadeh Kheirolomoom, Katherine W, Ferrara. (2007). Cholesterol transport from liposomal delivery vehicles. Biomaterials, 28, 4311-4320.
2. de Boer AG, Gaillard PJ. (2007). Drug targeting to the brain. Annu Rev Pharmacol Toxicol, 47, 323-355.
3. Janssen AP, Schiffelers RM, ten Hagen TL, Koning GA, Schraa AJ, Kok RJ, Storm G, Molema G. (2003). Peptide-targeted PEG-liposomes in anti-angiogenic therapy. Int J Pharm, 254, 55-58.
4. Beata Chertok, Allan E, David, Bradford A, Moffat, Victor C, Yang. (2009). Substantiating in vivo magnetic brain tumor targeting of cationic iron oxidenanocarriers via adsorptive surface masking. Biomaterials, 30, 1-8.
5. Celeste Roney, Padmakar Kulkarni, Veera Arora, Peter Antich, Frederick Bonte, Aimei Wu, N.N., Mallikarjuana, Sanjeev Manohar, Hsiang-Fa Liang, Anandrao R., Kulkarni, Hsing-Wen Sung, Malladi Sairam, Tejraj M., Aminabhavi. (2005). Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. Journal of Controlled Release, 108, 193-214.
6. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. (1996). Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem, 271, 18188-18193.
7. Diky Mudhakir, Hidetaka Akita, Erdal Tan, Hideyoshi Harashima. (2008). A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway. Journal of Controlled Release, 22, 164-173.
8. Loret EP, Vives E, Ho PS, Rochat H, Van Rietschoten J, Johnson WC Jr. (1991). Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization. Biochemistry, 30, 6013-6023.
9. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. (1994). Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA, 91, 664-668.
10. Belal F, Abdine H, Al-Majed A, Khalil NY. (2002). Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamine. J Pharm Biomed Anal, 27, 253-260.
11. Frangioni JV. (2003). In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol, 7, 626-634.
12. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. (2001). Arginine-rich peptides. An abundant source of membranepermeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem, 276, 5836-5840.
13. Gutierrez EG, Banks WA, Kastin AJ. (1993). Murine tumor necrosis factor a is transported from blood to brain in the mouse. J Neuroimmunol, 47, 169-176.
14. Hee Dong Han, Aeri Lee, Chung Kil Song, Taewon Hwang, Hasoo Seong, Chong Ock Lee, Byung Cheol Shin. (2006). In vivo distribution and antitumor activity of heparin-stabilized doxorubicinloaded liposomes. International Journal of Pharmaceutics, 313, 181-188.
15. Huali Chen Lei Tang, Yao Qin Yujia Yin, Jie Tang Wenwei Tang, Xun Sun Zhirong Zhang, Ji Liu Qin He. (2010). Lactoferrinmodified procationic liposomes as a novel drug carrier for brain Delivery. European Journal of Pharmaceutical Sciences, 40, 94-102.
16. Ines Sauer, Ildiko R. Dunay, Karl Weisgraber, Michael Bienert, Margitta Dathe. (2005). An Apolipoprotein E-Derived Peptide Mediates Uptake of Sterically Stabilized Liposomes into Brain Capillary Endothelial Cells. Biochemistry, 44, 2021-2029.
17. Jolliet-Riant P, Tillement JP. (1999). Drug transfer across the bloodbrain barrier and improvement of brain delivery. Fundam Clin Pharmacol, 13, 16-26.
18. Kim HR, Gil S, Andrieux K, Nicolas V, Appel M, Chacun H, Desmaële D, Taran F, Georgin D, Couvreur P. (2007). Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells. Cell Mol Life Sci, 64, 356-364.
19. Kitchens KM, Foraker AB, Kolhatkar RB, Swaan PW, Ghandehari H. (2007). Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res, 24, 2138-2145.
20. Lindgren M, Hällbrink M, Prochiantz A, Langel U. (2000). Cellpenetrating peptides. Trends Pharmacol Sci, 21, 99-103.
21. Lihong Liu, Kun Guo.; Jia Lu, Subbu S, Venkatraman, Dan Luo, Kian Chye Ng, Eng-Ang Ling, Shabbir Moochhala, Yi-Yan Yang. (2008). Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the bloodebrain barrier. Biomaterials, 29, 1509-1517.
22. May C., Miedel, Jeffrey D., Hulmes, Yu-Ching E., Pan, 1989. The use of fluorescamine as a detection reagent in protein microcharacterization. Journal of Biochemical and Biophysical Methods, 18, 37-52.
23. Mrsny RJ, Volwerk JJ, Griffith OH. (1986). A simplified procedure for lipid phosphorus analysis shows that digestion rates vary with phospholipid structure. Chem Phys Lipids, 39, 185-191.
24. Ntziachristos V, Bremer C, Weissleder R. (2003). Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol, 13, 195-208.
25. Orlandi PA, Fishman PH. (1998). Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol, 141, 905-915.
26. Pardridge WM. (1994). New approaches to drug delivery through the blood-brain barrier. Trends Biotechnol, 12, 239-245.
27. Santra S, Yang H, Stanley JT, Holloway PH, Moudgil BM, Walter G, Mericle RA. (2005). Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. Chem Commun (Camb), 3144-3146.
28. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. (1999). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 285, 1569-1572.
29. Schnitzer JE, Oh P, Pinney E, Allard J. (1994). Filipin-sensitive caveolaemediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol, 127, 1217-1232.
30. Futaki S, Ohashi W, Suzuki T, Niwa M, Tanaka S, Ueda K, Harashima H, Sugiura Y. (2001). Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem, 12, 1005-1011.
31. Shiroh Futaki. (2002). Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. International Journal of Pharmaceutics, 245, 1-7.
32. Temsamani J, Scherrmann JM. (2003). Peptide vectors as drug carriers. Prog Drug Res, 61, 221-238.
33. Temsamani J, Rousselle C, Rees AR, Scherrmann JM. (2001). Vectormediated drug delivery to the brain. Expert Opin Biol Ther, 1, 773-782.
34. Triguero D, Buciak J, Pardridge WM. (1990). Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem, 54, 1882-1888.
35. Vivés, E, Brodin, P, Lebleu, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem, 272, 16,010-16,017.
36. Torchilin VP, Rammohan R, Weissig V, Levchenko TS. (2001). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA, 98, 8786-8791.
37. Wadia JS, Dowdy SF. (2002). Protein transduction technology. Curr Opin Biotechnol, 13, 52-56.
38. Wellington Pham, Bing-Qiao Zhao, Eng H., Lo, Zdravka Medarova, Bruce Rosen, Anna Moore. (2005). Crossing the blood-brain barrier: A potential application of myristoylated polyarginine for in vivo neuroimaging. NeuroImage, 28, 287-292.
39. Yao Qin, Huali Chen, Wenmin Yuan, Rui Kua, Qianyu Zhang, Fulan Xie, Li Zhang, Zhirong Zhang, Ji Liu, Qin He. (2011). Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm, 420, 304-312.
40. Zhao M, Weissleder R. (2004). Intracellular cargo delivery using tat peptide and derivatives. Med Res Rev, 24, 1-12.